Description
SUDEEP PHARMA LIMITED will be added to the BSE IPO Index effective December 02, 2025, following its listing on BSE on November 28, 2025.
Summary
SUDEEP PHARMA LIMITED (Exchange ticker: 544619) will be added to the BSE IPO Index effective at the open of December 02, 2025. The company is being listed on BSE effective November 28, 2025. This is a standard index inclusion following the company’s initial public offering and listing.
Key Points
- SUDEEP PHARMA LIMITED (ticker: 544619) listing on BSE effective November 28, 2025
- Stock will be added to BSE IPO Index effective December 02, 2025 at market open
- Addition included in end-of-day corporate action file (*.SDE)
- Action follows reference to Notice No: 20251127-58
Regulatory Changes
No regulatory changes. This is a routine index composition update following an IPO listing.
Compliance Requirements
No specific compliance requirements for market participants. Index tracking funds and portfolio managers tracking the BSE IPO Index may need to adjust their holdings to reflect the new composition.
Important Dates
- November 28, 2025: SUDEEP PHARMA LIMITED listing effective on BSE
- December 02, 2025: Addition to BSE IPO Index effective at market open
Impact Assessment
Market Impact: Low. This is a routine index addition following an IPO. The BSE IPO Index tracks recently listed companies, and additions are expected as new IPOs occur.
Operational Impact: Minimal. Index funds and ETFs tracking the BSE IPO Index will need to rebalance portfolios to include the new constituent. The corporate action file has been updated to facilitate automated processing by market systems.
Investor Impact: Informational for investors tracking the BSE IPO Index. No action required for general market participants.
Impact Justification
Routine index addition following IPO listing; impacts only index composition tracking with no regulatory or compliance implications for market participants